Jordheim LP - Search Results

1

Enhanced migration of breast and lung cancer cells deficient for cN-II and CD73 via COX-2/PGE2/AKT axis regulation.

Cadassou O, Raza MZ, Machon C, Gudefin L, Armanet C, Chettab K, Guitton J, Tozzi MG, Dumontet C, Cros-Perrial E, Jordheim LP. Cadassou O, et al. Among authors: jordheim lp. Cell Oncol (Dordr). 2021 Feb;44(1):151-165. doi: 10.1007/s13402-020-00558-w. Epub 2020 Sep 24. Cell Oncol (Dordr). 2021. PMID: 32970317

2

Drug resistance to cytotoxic nucleoside analogues.

Jordheim L, Galmarini CM, Dumontet C. Jordheim L, et al. Curr Drug Targets. 2003 Aug;4(6):443-60. doi: 10.2174/1389450033490957. Curr Drug Targets. 2003. PMID: 12866659 Review.

3

Characterization of a gemcitabine-resistant murine leukemic cell line: reversion of in vitro resistance by a mononucleotide prodrug.

Jordheim LP, Cros E, Gouy MH, Galmarini CM, Peyrottes S, Mackey J, Perigaud C, Dumontet C. Jordheim LP, et al. Clin Cancer Res. 2004 Aug 15;10(16):5614-21. doi: 10.1158/1078-0432.CCR-04-0506. Clin Cancer Res. 2004. PMID: 15328204

4

Regulation and activity of cytosolic 5'-nucleotidase II. A bifunctional allosteric enzyme of the Haloacid Dehalogenase superfamily involved in cellular metabolism.

Bretonnet AS, Jordheim LP, Dumontet C, Lancelin JM. Bretonnet AS, et al. Among authors: jordheim lp. FEBS Lett. 2005 Jun 20;579(16):3363-8. doi: 10.1016/j.febslet.2005.05.014. FEBS Lett. 2005. PMID: 15946667 Free article. Review.

5

Increased expression of the large subunit of ribonucleotide reductase is involved in resistance to gemcitabine in human mammary adenocarcinoma cells.

Jordheim LP, Guittet O, Lepoivre M, Galmarini CM, Dumontet C. Jordheim LP, et al. Mol Cancer Ther. 2005 Aug;4(8):1268-76. doi: 10.1158/1535-7163.MCT-05-0121. Mol Cancer Ther. 2005. PMID: 16093443

6

Gemcitabine resistance due to deoxycytidine kinase deficiency can be reverted by fruitfly deoxynucleoside kinase, DmdNK, in human uterine sarcoma cells.

Jordheim LP, Galmarini CM, Dumontet C. Jordheim LP, et al. Cancer Chemother Pharmacol. 2006 Oct;58(4):547-54. doi: 10.1007/s00280-006-0195-8. Epub 2006 Feb 4. Cancer Chemother Pharmacol. 2006. PMID: 16463058

7

Review of recent studies on resistance to cytotoxic deoxynucleoside analogues.

Jordheim LP, Dumontet C. Jordheim LP, et al. Biochim Biophys Acta. 2007 Dec;1776(2):138-59. doi: 10.1016/j.bbcan.2007.07.004. Epub 2007 Aug 14. Biochim Biophys Acta. 2007. PMID: 17881132 Review.

8

Differential allelic expression in leukoblast from patients with acute myeloid leukemia suggests genetic regulation of CDA, DCK, NT5C2, NT5C3, and TP53.

Jordheim LP, Nguyen-Dumont T, Thomas X, Dumontet C, Tavtigian SV. Jordheim LP, et al. Drug Metab Dispos. 2008 Dec;36(12):2419-23. doi: 10.1124/dmd.108.023184. Epub 2008 Sep 5. Drug Metab Dispos. 2008. PMID: 18775979

9

Development of gene therapy in association with clinically used cytotoxic deoxynucleoside analogues.

Hébrard C, Dumontet C, Jordheim LP. Hébrard C, et al. Among authors: jordheim lp. Cancer Gene Ther. 2009 Jul;16(7):541-50. doi: 10.1038/cgt.2009.25. Epub 2009 Apr 3. Cancer Gene Ther. 2009. PMID: 19343063 Review.

10

Simultaneous analysis of eight nucleoside triphosphates in cell lines by liquid chromatography coupled with tandem mass spectrometry.

Cohen S, Megherbi M, Jordheim LP, Lefebvre I, Perigaud C, Dumontet C, Guitton J. Cohen S, et al. Among authors: jordheim lp. J Chromatogr B Analyt Technol Biomed Life Sci. 2009 Nov 15;877(30):3831-40. doi: 10.1016/j.jchromb.2009.09.030. Epub 2009 Sep 25. J Chromatogr B Analyt Technol Biomed Life Sci. 2009. PMID: 19805008

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

100 results

Search Page

Filters